ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook [Yahoo! Finance]
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: McBride John S.
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Katkin Keith
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Hillson Jan
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Kirk Allan
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Lee June
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.